Lombard Medical Technologies Share Discussion Threads

[philo124] 29/2/2012 12:50

Finally got in after missing 0.6 when CS appointed broker-their target price -1.9p
My 250k BUY reported as a sell. LOL.

[falia] 21/2/2012 10:34

2P ON THE CARDS

[stable] 21/2/2012 08:45

It would be nice to know if recent big rise is due to broker/paper chat or someone with insider knowledge. We await USA news which we know to be due within the next few months.

[balcony] 27/1/2012 08:25

Would be good to see the new guy buy some shares,I think he will

[philo124] 23/1/2012 15:37

There's is more dilution to come on FDA approval if you remember the terms of the last financing @ 0.7p.
Having said that i did have them on my watch list & had spoken to my broker
about buying them the day before the big rise (didn't), so, sour grapes maybe on my side.

[stable] 23/1/2012 15:23

jotoha2
I was hoping that you had something more concrete for your valuation other than rumour.
If invesco expect 10 fold then the out price has to be 7p at least . I cannot remember anything lower than .70 being traded in volume.

The highest expected forecast that I have seen was 3.0p but I expect that you are more upto date than me.
U said ''lets start with'' have you some more info for your valuation to drip feed to us?

[jotoha2] 23/1/2012 11:23

Well lets start with Invesco , who have openly stated that they expect a ten fold return on their investment , and by all accounts feel this is on track for this year.

[philo124] 22/1/2012 20:25

Please enlighten us on the calculation to get to £(!)300 million as it would seem you have already done the "maths". TIA.

[jotoha2] 22/1/2012 20:21

£300 million takeout is being planned for 3rd qtr this year , do the maths , its a great investment!!

[andrbea] 19/1/2012 10:02

top riser at present
up 18%

[skinny] 17/1/2012 07:26

RNS Number : 6563V

Lombard Medical Technologies PLC

17 January 2012

Lombard Medical Technologies PLC

("Lombard Medical" or "the Company")

Appointment of New CFO

London, UK, 17 January 2012 - Lombard Medical Technologies PLC (AIM: LMT), the specialist medical technology company focussed on innovative vascular products, is pleased to announce the appointment of Ian Ardill to the Board as Chief Financial Officer, with effect from January 23(rd) 2012.

Ian joins Lombard Medical after leaving Biocompatibles International plc, a listed medical technology company, where he was Finance Director for over six years after joining in 2003 as Financial Controller and Company Secretary. Ian played a leading role in transforming the business from a loss making company to a profitable enterprise with sales of GBP33 million and latterly overseeing the successful sale of the business for GBP177 million to BTG plc in 2011.

Before joining Biocompatibles, Ian worked at Novartis Pharmaceuticals UK Limited, in a variety of senior roles that encompassed accounting, systems implementation and treasury (1997-2002). Ian has also held the positions of: Finance Director of Letheby & Christopher Ltd (a subsidiary of Compass Group PLC, 1994-1997), Finance and Planning Manager at NHA International plc (1993-1994) and worked within the corporate finance team at Grant Thornton (1988-1992).

Ian Leslie Ardill (aged 44), qualified as a Chartered Accountant in 1990 and holds an Accounting and Financial Analysis degree from Warwick University.

[skinny] 17/1/2012 07:25

17 January 2012

Lombard Medical Technologies PLC

("Lombard Medical" or "the Company")

Change of Nominated Adviser and Broker

London, UK, 17 January 2012 - Lombard Medical Technologies PLC (AIM: LMT), the specialist medical technology company focussed on innovative vascular products, is pleased to announce the appointment of Collins Stewart Europe Limited as Nominated Adviser and Broker to the Company with immediate effect.

- Ends -

[bbluesky] 12/1/2012 20:38

"A New Dawn" has always been of the Somme variety.... Lots of pharma in the States hitting new highs. Encouraging.

[sodium999] 12/1/2012 19:56

I brought on Tom Bulford's INFO @ 0.58 didnt stay with it ...see it is 0.68

should have suppose

[shortearedowl] 27/12/2011 15:10

I see Tom Bulford included LMT as a front runner in his "Hope Springs Eternal" category for the 2011 Penny Sleuth awards, quantifying it as one of those that promised much but failed to deliver. Too right and it didn't even win - typical - Lol!

[troutisout] 01/12/2011 13:01

Updated info on the PEER thread, with M&A activity happening it's worthwhile watching some of these Medical small caps

[eddington1972] 29/11/2011 12:56

Probably next year

[seangwhite] 29/11/2011 12:55

Still quiet here when will we get news?

[sowingandgrowing] 20/9/2011 22:44

Might get back into these at 0.25 , worked out well a few years ago

[webshares] 30/8/2011 17:21

probably, but they won't deliver on time....

i know i know still bitter ha

[dollarman3] 27/8/2011 23:15

very quiet here,is there any news expected anytime soon

[troutisout] 08/7/2011 07:47

troutisout - 7 Jul'11 - 15:06 - 15 of 21 edit


Right I have gone back over ADVFN's info and have come up with this,

LID EV/Sales 28.18/6.24......4.52
DEMG EV/Sale 35.41/6.28......5.64
ASD EV/Sales 259.84/101.68...2.56 - PE 45
ODX EV/Sales 13.5/7.9........1.71 - PE 155
MDW EV/Sales 3.06/10.48......0.29 - PE 14.08
AOR EV/Sales 4/1.36..........2.94
LMT EV/Sales 30.48/3.01.....10.13
XCT EV/Sales 8.13/3.1........2.62
TSTL EV/Sale 14.25/8.76......1.63 - PE 12
SUN EV/Sales 39/7.05.........5.53 - PE 21.61


Well from the table above we can see some wild differences in each valuation factor.
Using ASD as an example (as we know what a comnpetitor was prepared to offer) it doesn't seem to have been the PE ratio that it was worked from, the Ev/sales figure of 2.56 looks to be in the centre of the range.

so are EV/Sales the best way to look at value, certainly with so many not actually in profit PE and PEG are out the window.

I would like to look more into forecast PEs but will need to see broker forecasts if there are any on some of the above shares, if anyone can post a link to any forecasts for any of the above, it will be greatly appreciated.


Come and add any facts you can on these and any other smallcap medical equipment companies,

[skinny] 29/6/2011 08:53

RNS Number : 2986J

Lombard Medical Technologies PLC

29 June 2011

Lombard Medical Technologies PLC

("Lombard Medical" or "the Company")

Regulatory Update

London, UK, 29 June 2011 - Lombard Medical Technologies PLC, a medical devices company focused on device solutions for the $1.1 billion dollar abdominal aortic aneurysm repair market, today provides an update on the U.S. regulatory process for its lead product, the Aorfix(TM) stent graft.

The Company has filed five of the six PMA (Pre-Market Approval) modular filings required for its FDA (Food and Drug Administration) submission and three of these have been accepted by the FDA. As announced in April 2011, the FDA responded with questions related to modules four (engineering, bench testing and shelf-life) and five (manufacturing). The Company has submitted comprehensive responses to all questions and continues to perform confirmatory bench testing, which will be available later this year.

Module six, the final clinical module, has been prepared for submission and on 2 June 2011, the Company completed and submitted its Statistical Analysis Plan (Sap) to the FDA. The SAP is the first part of the module six submission with a review period of up to 30 days. The full module will be filed once review of the SAP has been completed. Following submission, the FDA will have up to 180 days in which to review the final module and respond to the Company. The Company continues to anticipate FDA approval of Aorfix(TM) between the first and third quarters of 2012.

- Ends -

[rayrac] 04/6/2011 20:21

Actually, I did quite well out of this when they changed their setup/name. Had a large cheque in the post!